CD4 and Parkinson disease: Notably, CD4 + T cells may recognize α-synuclein epitopes via molecular mimicry, triggering autoimmune responses against dopaminergic neurons [9], a process supported by the detection of α-synuclein-specific T cell receptor (TCR) clones in the serum and cerebrospinal fluid of PD patients [10].